The Aβ story: rehabilitation of a bad boy

Robert D. Moir Genetics and Aging Research Unit, Mass General Institute for Neurodegenerative Disease; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA       Deposition of amyloid-β peptide (Aβ) as β-amyloid plaques is the hallmark pathology for Alzheimer’s disease (AD). For over 30 years therapeutic strategies to treat AD […]

from The Evolution and Medicine Review http://ift.tt/2i7OZgY